HEALTHFINANCIAL TIMES WORLD
Inside Palantir’s fight over the future of the NHS
Palantir's software, intended to address chronic waiting lists in the UK's NHS, has sparked controversy for the US-based tech company. The solution aimed at improving public health service efficiency has become a point of contention.
Related Signal
Adjacent reporting
- The Palantir controversy is a block on NHS progress
- Met Palantir row gets to heart of how public services should use AI
- Why you can never get your doctor to call you back
- Palantir defends its record as MPs demand more scrutiny of data use
- Health secretary urged not to bow to Zack Polanski's demand to cancel 'transformative' NHS technology over tech giant Palantir's links to Donald Trump
- What NHS challenges does the election winner face?